DENTSPLY SIRONA (XRAY) Price Target Lowered to $46.00 at Stifel Nicolaus

By Egypt Independent

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective lowered by Stifel Nicolaus from $57.00 to $46.00 in a research note issued to investors on Wednesday morning, Marketbeat.com reports. The brokerage currently has a buy rating on the medical instruments suppliers stock.

XRAY has been the topic of a number of other research reports. ValuEngine lowered shares of DENTSPLY SIRONA from a sell rating to a strong sell rating in a report on Tuesday, May 8th. Morgan Stanley cut their price target on shares of DENTSPLY SIRONA from $65.00 to $54.00 and set an overweight rating on the stock in a report on Thursday, June 14th. Barclays restated a hold rating and set a $55.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, May 8th. BidaskClub upgraded shares of DENTSPLY SIRONA from a strong sell rating to a sell rating in a report on Wednesday, June 13th. Finally, Barrington Research cut their price target on shares of DENTSPLY SIRONA from $70.00 to $54.00 and set an outperform rating on the stock in a report on Tuesday, May 8th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $52.75.

XRAY stock traded down $0.26 on Wednesday, hitting $40.12. 3,401,099 shares of the companys stock traded hands, compared to its average volume of 2,602,779. DENTSPLY SIRONA has a 1-year low of $38.83 and a 1-year high of $68.98. The firm has a market cap of $11.02 billion, a PE ratio of 15.37, a P/E/G ratio of 2.51 and a beta of 1.27. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.23 and a quick ratio of 1.46.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the consensus estimate of $0.59 by $0.01. DENTSPLY SIRONA had a negative net margin of 38.32% and a positive return on equity of 8.63%. The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same period in the prior year, the business earned $0.65 earnings per share. sell-side analysts expect that DENTSPLY SIRONA will post 2.59 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 12th. Shareholders of record on Friday, September 28th will be paid a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.35 annualized dividend and a yield of 0.87%. DENTSPLY SIRONAs dividend payout ratio is presently 13.16%.

In other DENTSPLY SIRONA news, Director Michael C. Alfano sold 1,404 shares of the companys stock in a transaction that occurred on Wednesday, May 30th. The shares were sold at an average price of $45.83, for a total value of $64,345.32. Following the transaction, the director now owns 13,458 shares in the company, valued at approximately $616,780.14. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Michael J. Coleman sold 6,038 shares of the companys stock in a transaction that occurred on Friday, June 1st. The shares were sold at an average price of $43.97, for a total transaction of $265,490.86. Following the completion of the transaction, the director now owns 26,960 shares in the company, valued at approximately $1,185,431.20. The disclosure for this sale can be found here. 1.93% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. Jane Street Group LLC bought a new stake in DENTSPLY SIRONA in the fourth quarter worth approximately $313,000. Global X Management Co. LLC grew its position in DENTSPLY SIRONA by 24.1% in the first quarter. Global X Management Co. LLC now owns 10,350 shares of the medical instruments suppliers stock worth $521,000 after acquiring an additional 2,009 shares in the last quarter. Veritas Asset Management LLP grew its position in DENTSPLY SIRONA by 37.2% in the first quarter. Veritas Asset Management LLP now owns 8,417,655 shares of the medical instruments suppliers stock worth $423,492,000 after acquiring an additional 2,281,200 shares in the last quarter. Wells Fargo & Company MN grew its position in DENTSPLY SIRONA by 35.6% in the first quarter. Wells Fargo & Company MN now owns 884,819 shares of the medical instruments suppliers stock worth $44,515,000 after acquiring an additional 232,068 shares in the last quarter. Finally, S&CO Inc. grew its position in DENTSPLY SIRONA by 10.8% in the first quarter. S&CO Inc. now owns 36,257 shares of the medical instruments suppliers stock worth $1,824,000 after acquiring an additional 3,537 shares in the last quarter. Hedge funds and other institutional investors own 94.10% of the companys stock.

This article provided by NewsEdge.